LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $164,000 | +21.5% | 13,650 | -0.4% | 0.00% | 0.0% |
| Q4 2017 | $135,000 | -91.9% | 13,700 | -89.9% | 0.00% | -89.5% |
| Q3 2017 | $1,659,000 | +267.0% | 135,000 | +440.0% | 0.02% | +280.0% |
| Q3 2016 | $452,000 | -60.6% | 25,000 | -68.8% | 0.01% | -28.6% |
| Q2 2016 | $1,148,000 | +140.2% | 80,000 | +100.0% | 0.01% | +16.7% |
| Q1 2016 | $478,000 | -10.2% | 40,000 | 0.0% | 0.01% | -14.3% |
| Q4 2015 | $532,000 | -23.8% | 40,000 | -38.5% | 0.01% | -22.2% |
| Q3 2015 | $698,000 | – | 65,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |